Long-term outcomes of frontline 90Y-ibritumomab tiuxetan in marginal zone lymphoma

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)3234-3238
Number of pages5
JournalLeukemia and Lymphoma
Volume61
Issue number13
DOIs
StatePublished - 2020
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this